{
  "id": 2281,
  "text": "1922</td><td>2008</td><td>1</td><td>CisP, VinC</td><td>PD</td><td>CT/RT</td><td>10</td><td>DOD</td><td>well</td></tr><tr><td>Seamon et al.1923</td><td>2009</td><td>1</td><td>CisP, VinC</td><td>PR</td><td>RT</td><td>48</td><td>NED</td><td>well</td></tr></table></body></html> Adria adriamycin, AWD alive with disease, Bleo bleomycin, BT brachytherapy, Carbo carboplatin, CisP cisplatin, CR complete response, CS cesarean section, CT chemotherapy, Cyclo cyclophosphamide, Dac dactinomycin, DOD dead of disease, Eto etoposide, NACT neoadjuvant chemotherapy, NED no evidence of disease, nr not reported, PALND para-aortic lymph node dissection, PLND pelvic lymph node dissection, PR partial response, RH radical hysterectomy, RT radiation therapy, SD stable disease, Tax paclitaxel, VinC vincristine Table 51.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1922</td><td>2008</td><td>1</td><td>CisP, VinC</td><td>PD</td><td>CT/RT</td><td>10</td><td>DOD</td><td>well</td></tr><tr><td>Seamon et al.1923</td><td>2009</td><td>1</td><td>CisP, VinC</td><td>PR</td><td>RT</td><td>48</td><td>NED</td><td>well</td></tr></table></body></html> Adria adriamycin, AWD alive with disease, Bleo bleomycin, BT brachytherapy, Carbo carboplatin, CisP cisplatin, CR complete re\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "联合放疗和化疗，如使用顺铂（CisP）和长春地辛（VinC）的治疗方案在不同患者中的生存结果和治疗效果可能存在显著差异。根据不同病例，患者的病情反应可能表现为部分缓解（PR），以及一段时间后无病生存状态（NED）；然而，也有病例在治疗后出现疾病恶化并最终死亡（DOD）。实际上，治疗的效果不仅受药物类型影响，还与患者具体病情、癌症的分期、身体状况以及个体对治疗的耐受性有关。因此，疗效评估应结合具体临床情况进行，且个性化治疗方案的制订对患者的长期生存状态具有重要意义。",
  "query": "**问题**: 根据不同治疗方案，像是联合放疗和化疗（例如使用CisP和VinC）后，患者的生存状态和治疗效果可能有哪些不同？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **问题**: 根据不同治疗方案，像是联合放疗和化疗（例如使用CisP和VinC）后，患者的生存状态和治疗效果可能有哪些不同？\n\n<reference text>: 1922</td><td>2008</td><td>1</td><td>CisP, VinC</td><td>PD</td><td>CT/RT</td><td>10</td><td>DOD</td><td>well</td></tr><tr><td>Seamon et al.1923</td><td>2009</td><td>1</td><td>CisP, VinC</td><td>PR</td><td>RT</td><td>48</td><td>NED</td><td>well</td></tr></table></body></html> Adria adriamycin, AWD alive with disease, Bleo bleomycin, BT brachytherapy, Carbo carboplatin, CisP cisplatin, CR complete response, CS cesarean section, CT chemotherapy, Cyclo cyclophosphamide, Dac dactinomycin, DOD dead of disease, Eto etoposide, NACT neoadjuvant chemotherapy, NED no evidence of disease, nr not reported, \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "联合放疗和化疗，如使用顺铂（CisP）和长春地辛（VinC）的治疗方案在不同患者中的生存结果和治疗效果可能存在显著差异。根据不同病例，患者的病情反应可能表现为部分缓解（PR），以及一段时间后无病生存状态（NED）；然而，也有病例在治疗后出现疾病恶化并最终死亡（DOD）。实际上，治疗的效果不仅受药物类型影响，还与患者具体病情、癌症的分期、身体状况以及个体对治疗的耐受性有关。因此，疗效评估应结合具体临床情况进行，且个性化治疗方案的制订对患者的长期生存状态具有重要意义。"
}